LRRK2 and Parkinson disease: Our novel protocol quantitatively assesses both LRRK2 and GCase enzymatic activity levels in monocytes gated from total PBMCs via flow cytometry; two readouts which are highly relevant to the PD field and are highly implicated in monocyte physiology.